JIANMIN GROUP: Furosemide oral solution approved for market launch
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, JIANMIN GROUP announced that the oral solution of Furosemide developed by the company has been approved for marketing by the National Medical Products Administration. The approval of the chemical generic drug oral solution of Furosemide will further enrich the company's product line, enhance the company's core competitiveness, and have a positive impact on the company's future development
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments